Asthma and rhinitis are two of the main clinical manifestations of allergy, in which increased reactive oxygen or electrophilic species can play a pathogenic role. Aldose reductase (AKR1B1) is involved in aldehyde detoxification and redox balance. Recent evidence from animal models points to a role of AKR1B1 in asthma and rhinitis, but its involvement in human allergy has not been addressed. Here, the putative association of allergic rhinitis and asthma with AKR1B1 variants has been explored by analysis of single-strand variants on the AKR1B1 gene sequence in 526 healthy subjects and 515 patients with allergic rhinitis, 366 of whom also had asthma. We found that the rs2229542 variant, introducing the p.Lys90Glu mutation, was significantly more frequent in allergic patients than in healthy subjects. Additionally, in cells transfected with expression vectors carrying the wild-type or the p.Lys90Glu variant of AKR1B1, the mutant consistently attained lower protein levels than the wild-type and showed a compromised thermal stability. Taken together, our results show that the rs2229542 variant associates with asthma and rhinitis, and hampers AKR1B1 protein levels and stability. This unveils a connection between the genetic variability of aldose reductase and allergic processes.
INTRODUCTION
Aldose reductase, also known as aldo-keto reductase 1B1 (AKR1B1, MIM# 103880, EC. 1.1.1.21), catalyzes the conversion of glucose to sorbitol utilizing NADPH as cofactor, which constitutes the first reaction of the polyol pathway. In addition, AKR1B1 metabolizes reactive aldehydes and ketones, which could be deleterious to cells, and is therefore considered to play a protective role under physiological conditions (Petrash, 2004) . AKR1B1 is itself a target for modification by several reactive species, which may impact positively or negatively on its activity, depending on the modifying moiety (Díez-Dacal et al., 2011; Sánchez-Gómez et al., 2016; Srivastava, Ramana, Chandra, Srivastava, & Bhatnagar, 2003) , thus modulating its ability to cope with oxidative or electrophilic stress. Nevertheless, in pathophysiological situations, the activity of aldose reductase may display a negative side and participate in disease mechanisms (Ramana & Srivastava, 2010) .
The pathological implications of AKR1B1 have been mainly studied in diabetes. In this condition, hyperglycemia forces glucose metabolism through the polyol pathway (Petrash, 2004) , which elicits multiple consequences. First, excess sorbitol can induce osmotic stress. Moreover, consumption of the NADPH cofactor (Lee & Chung, 1999) , which is needed for the regeneration of cellular antioxidant defenses, including glutathione (GSH), peroxiredoxins, and thioredoxin (Pollak, Dolle, & Ziegler, 2007) , can provoke redox imbalance reducing the cellular capacity to respond to oxidative stress. Aldose reductase can also contribute to oxidative stress-induced inflammation . Reactive oxygen species (ROS) generated in inflammatory situations lead to reactive oxidized lipid species, like 4-hydroxynonenal, which in turn can form GSH adducts. Both, the reactive aldehydes and their GSH adducts, serve as substrates for aldose reductase. However, the resulting products, like 1,4-dihydroxynonene and glutathionyl-1,4-dihydroxynonane, can stimulate proinflammatory signaling cascades, originating a positive feedback of inflammation (Ramana et al., 2006) .
In addition, the finding that AKR1B1 metabolizes prostaglandins suggests novel implications of this enzyme in the balance of inflammatory mediators, not completely understood (Bresson, Lacroix-Pepin, Boucher-Kovalik, Chapdelaine, & Fortier, 2012) . Lastly, the ability of several AKR enzymes to detoxify reactive species and drugs can contribute to tumor cell chemoresistance (Díez-Dacal & Pérez-Sala, 2012; Díez-Dacal et al., 2011) .
Interestingly, recent work in cellular and animal models suggests the involvement of aldose reductase in allergy. In murine models, both genetic and pharmacological blockade of this enzyme play a protective role against airway inflammation, reducing eosinophil infiltration and airway hyper-responsiveness (Yadav et al., 2009; Yadav, AguileraAguirre, Boldogh, Ramana, & Srivastava, 2011) . In addition, aldose reductase inhibition has been reported to prevent allergic rhinitis, inhibit mast cell degranulation and tryptase release (Yadav et al., 2013 ).
Yet, it remains unknown whether these protective outcomes arise from a general anti-inflammatory effect or from specific anti-allergic actions. The available evidence suggests that the protective effects of AKR1B1 inhibition or knockdown may arise from blocking its role as mediator of oxidative stress-induced inflammation . Indeed, ROS and ROS-induced lipid peroxidation have been involved in the pathophysiology of asthma and allergic rhinitis (Bowler & Crapo, 2002; Sahiner, Birben, Erzurum, Sackesen, & Kalayci, 2011; Sánchez-Gómez et al., 2016) . Nevertheless, whether AKR1B1 plays a pathogenic role in human allergy has not been assessed. AKR1B1 belongs to the AKR family of enzymes, which comprises more than 40 members that are highly polymorphic. The AKR1B1 gene is located on chromosome 7q33 (dbSNP release 142) and contains 10 exons. Several AKR1B1 variants have been found to associate with pathological conditions (Penning & Drury, 2007) . For example, the rs759853 variant (c.-144C > T), located at the gene promoter, is associated with the susceptibility to suffer diabetic complications, including diabetic retinopathy and nephropathy (Kao, Donaghue, Chan, Knight, & Silink, 1999; Moczulski et al., 1999) , or other pathologies such as essential hypertension (Wang et al., 2016) . However, the existence of AKR1B1 variants related to allergic reactions has not been reported.
With this background we set out to explore the potential existence of aldose reductase variants associated to allergy. Allergic rhinitis provides an interesting field of study due to the importance of genetic factors in this condition and its frequent association with asthma Van Cauwenberge et al., 2007) . Therefore, we assessed the presence of three known AKR1B1 variants in patients with allergic rhinitis and healthy subjects, namely, the rs5053 variant (c.-49C>G) (Prasad et al., 2010) (Figure 1A ), consisting in a G>C mutation at the 5 ′ UTR region; the rs150113325 variant (c.429+6A>G), that generates a splicing variant; and the variant rs2229542 (c.268A>G), consisting in an A to G single mutation in the coding region, resulting in the p.Lys90Glu mutation. Among these three variants, the rs2229542 affects the AKR1B1 mRNA ( Figure 1B) , whereas the other two are located in nontranslated regions of the gene.
Here, we report the association of the rs2229542 (c.398A>G) variant with allergic rhinitis, as well as the potential impact of this change on protein levels. This is the first evidence of a variant in a member of the AKR family related to the development of an allergic response.
MATERIALS AND METHODS

Clinical evaluation
A cohort of 1041 Caucasian individuals, including 526 healthy subjects and 515 allergic rhinitis patients, whose clinical features have been summarized previously (Amo et al., 2016) , was studied. Patients were recruited from the Allergy Department, Infanta Cristina Hospital (Badajoz, Spain) and from the UGC Allergy, Regional Hospital (Málaga, Spain) (265 and 250 patients, respectively) and most of them have been included in previous studies (Gervasini et al., 2010) . Diagnosis of allergic rhinitis within the cohort was undertaken by an allergy specialist following the current ARIA guidelines (Brozek et al., 2010) . All patients had a positive skin prick test for at least one relevant aeroallergen. Among the 515 patients, 366 (71.1%) were diagnosed of allergic asthma, according to Global Initiative for Asthma guidelines (Reddel et al., 2015) . Healthy subjects from the same ethnicity and geographic area were selected from the personnel staff and medical students belonging to the Hospitals and the Universities participating in the study. Their medical histories were obtained and examinations were carried out to discard pre-existing disorders. Subjects with familiar, up to second-degree relatives, or personal antecedents of allergic, atopic or autoimmune diseases were excluded.
All participants read and signed the written consent for their participation in the study. All the protocols and practices undertaken in this study were in accordance with the Declaration of Helsinki and the sub- 
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Genotype analysis
Genomic DNA from leukocytes was isolated and purified follow- The variants rs139346970 (splice acceptor), rs73724958 (missense), and rs115638419 (missense) were not studied due to their absence in Caucasians.
Database searching and theoretical predictions
AKR sequences were aligned using CLUSTALW. Predictions of p.Lys90 posttranslational modifications were obtained from GeneCards Human Gene Database (Weizmann Institute of Science) and UbPred: predictor of protein ubiquitination sites (Radivojac et al., 2010) .
Nuclear localization/export signals were predicted with NetNES and PSORT II. The impact of the mutation was evaluated with PredictProtein. Structural analysis was carried out with PyMOL (v1.7.435; Schrödinger LLC, New York, NY, USA) using the human aldose reductase crystal structure (1PWL). The SNPeffect 4.0 server database was searched to obtain the theoretical impact of the p.Lys90Glu mutation on AKR1B1 stability. Detailed information regarding the software or servers used is provided in the Supp. Table S1 . 
Cell culture, treatments, and sample processing
Plasmids and transfections
The mammalian expression vector of human AKR1B1 was from Origene (Rockville, MD). The AKR1B1 p.Lys90Glu mutant was generated by site-directed mutagenesis using the QuikChange II mutagenesis kit (Agilent Technologies, Las Rozas, Spain) and oligonucleotides containing the mutation (underlined): sense, 5 ′ -GGGCCTGGTGGAA GGAGCCTGCCAG-3 ′ ; antisense, 5 ′ -CTGGCAGGCTCCTTCCACCAG GCCC-3 ′ . Both wild-type (WT) and mutant expression vectors were fully sequenced to ensure identity of the remaining plasmid sequence. TA B L E 1 AKR1B1 genotypes in control individuals, overall rhinitis patients, rhinitis alone patients, and rhinitis + asthma patients 
RNA isolation and qPCR
Cellular thermal stability assay
The effect of the mutation on protein stability was studied by means of cellular thermal stability assay (CETSA). MCF7 cells transfected with WT or p.Lys90Glu AKR1B1 plasmids were harvested in PBS, containing protease and phosphatase inhibitors, as previously described (Sánchez-Gómez et al., 2007) , but in the absence of detergents. Cells were homogenized by three freeze-thaw cycles using dry ice-ethanol.
Lysates were centrifuged at 20,000 × g for 20 min at 4 protein signal (supernatant + pellet = 100 %) at each temperature and plotted against temperature using GraphPad Prism (GraphPad Software, La Jolla, CA, USA). Each data set was fitted to a variable slope sigmoidal curve by least squares using the following Equation (1):
The parameters in the equation were: A, the relative signal intensity at each temperature; B, value of the plateau at the bottom of the curve;
C, value of the plateau at the top of the curve; T m50 , melting temperature; D, temperature; and E, the slope of the curve.
Statistical analysis
Statistical analyses were performed with the SPSS software version 19.0 for Windows (SPSS, Chicago, IL). Genotype, allelic, and HardyWeinberg equilibrium analyses were performed with PLINK40 software. Comparison of alleles and genotypes frequencies between controls and patients was undertaken with the 2 statistics or Fisher exact test, as appropriate. The putative association between the SNPs and the risk of developing allergic rhinitis was estimated by the odds ratio (OR) and the 95% confidence interval (CI). False discovery rate correction was used for the multiple comparison adjustments (Benjamini, Drai, Elmer, Kafkafi, & Golani, 2001) . Results from MCF7 cell transfection experiments are expressed as mean ± SEM of three independent experiments. Differences between experimental conditions were analyzed by Student's t-test "paired test" when normality tests were not supported by the data and considered significant when P ≤ 0.05.
RESULTS
Study of the association between AKR1B1 variants and rhinitis
The cohort of patients considered has been included in a previous study (Amo et al., 2016) where the general parameters regarding clinical characterization have been described. Briefly, there were no statistically significant differences between patients and control subjects regarding gender or age, whereas the percentage of smokers was lower in rhinitis plus asthma patients than in control subjects (Chi-Square test P = 0.002) (Amo et al., 2016) .
The frequencies for AKR1B1 genotypes in control subjects and overall rhinitis patients are summarized in Table 1 . Statistical analyses showed a significant increase in the frequency for the nonsynonymous variant rs2229542 in heterozygosity in overall patients (Table 1 ). The rs5053 variant showed a slightly higher frequency, although nonstatistically significant.
Overall patients were classified into two subgroups considering their clinical manifestations: patients with allergic rhinitis alone and patients presenting rhinitis plus asthma. Analysis of the distribution frequency of each variant in the sub-cohort of patients with rhinitis alone showed a statistically significant higher association of the rs2229542 variant in heterozygosity compared to controls, similar to that observed in the overall population (Table 1) . For the other two variants there is a trend towards a higher frequency in heterozygous patients compared to control subjects.
In the second subset of patients, presenting rhinitis plus asthma, there was also a statistically significant higher frequency for the variant rs2229542 in heterozygosity compared to the control population (Table 1) . Again, a trend for a higher frequency of the rs5053 variant was observed in the patients' group.
Altogether, the analyses of variants in the overall population and in the two population subsets support the association between the p.Lys90Glu mutation and the presence of allergic rhinitis.
Study of the p.Lys90Glu aldose reductase mutant
The association between rhinitis and the rs2229542 variant suggests that the p.Lys90Glu (K90E) mutation could have structural or functional implications. To gain insight into the potential structural changes induced by this mutation we first examined the available crystal structure of AKR1B1 (1PWL) (Figure 2 ). The p.Lys90Glu substitution exchanges the native positive charge of the lysine residue for the negative charge of the glutamic acid carboxylic group (Figure 2A and   B) . Moreover, this mutation implies a change in the orientation of the amino acid lateral chain, which can also be observed in the ribbon plots F I G U R E 2 Structural impact of the p.Lys90Glu mutation. The human AKR1B1 crystal structure (1PWL) was used to prepare the figure using PyMOL. The lysine residue of interest was numbered according to the AKR1B1 sequence as p.Lys90 (K90; red sticks) and the corresponding mutant as p.Lys90Glu (K90E; orange sticks) in all the panels. A: Molecular surface of wild-type AKR1B1. B: Molecular structure of the p.Lys90Glu mutant. C: Ribbon structure of the wild-type protein, showing the p.Lys90 lateral chain. D: Ribbon structure including the lateral chain of the p.Lys90Glu mutant. E: Ribbon plot of the sequence comprising residues p.Lys77 to p.Leu101 of wild-type AKR1B1 (left), including the -helix containing p.Lys90, and molecular surface of the area surrounding p.Lys90 (right), highlighting the negative (red), and positive charges (blue). F: Ribbon plot of the same sequence stretch (left), and molecular surface area (right) but including the mutated lateral chain. In all cases, the mutated lateral chains depicted include the protonated form of glutamic acid ( Figure 2C and D) , and alters the balance between charges in this area ( Figure 2E and F).
Putative functional effects of the p.Lys90Glu mutation were To explore whether the lower protein levels of the p.Lys90Glu mutant resulted from reduced expression, qPCR was performed to measure the steady-state mRNA levels. No differences were found between AKR1B1 transcript levels in cells transfected with the WT or the p.Lys90Glu forms, whereas they were virtually undetectable in mock-transfected cells. These results were consistent with any of the three reference genes used in the assay, namely, RNA18S1 ribosomal subunit, HPRT1 and GAPDH ( Figure 5 ). Hence, these data indicate that the differences in protein levels reached by the WT and p.Lys90Glu AKR1B1 are due to posttranscriptional mechanisms, potentially affecting protein translation or stability.
Effect of the p.Lys90Glu mutation on AKR1B1 protein stability
To explore putative effects of the p.Lys90Glu (K90E) mutation in protein stability, we carried out in silico calculations using the amino acid 
DISCUSSION
Increased aldose reductase activity is a well-established pathogenic factor for several diseases, for which it is considered a crucial drug target (Díez-Dacal et al., 2016). Accumulating evidence indicates F I G U R E 4 Levels of AKR1B1 attained upon transfection of wildtype and p.Lys90Glu constructs using different transfection agents and in several cell types. A: AKR1B1 wild-type (WT) or p.Lys90Glu (K90E) expression vectors were transfected in MCF7 cells utilizing Lipofectamine 2000, FuGene or TransIT transfection agents. Levels of AKR1B1 were assessed by Western blot with a specific antibody (upper panel) or with a pan-AKR antibody (middle panel) to ensure that the differences observed were not due to poor recognition of the p.Lys90Glu mutant by the specific antibody. B: Bovine aortic endothelial cells were transfected with AKR1B1 WT or p.Lys90Glu vectors, or mock-transfected, and AKR1B1 protein levels were analyzed by Western blot. Actin was used as a house-keeping protein control. Results are representative of at least two experiments that it plays a complex role in inflammation Srivastava et al., 2011) . Also, reports from animal models put forward a role for aldose reductase in allergy Yadav et al., 2013) . Given that AKR enzymes are considered highly Given their role in detoxification, AKR variants could afford interindividual variability in the metabolism of endogenous carbonylcontaining compounds, including ketosteroids, ketoprostaglandins, and retinoids, as well as of exogenous chemicals (Penning & Drury, 2007; Ruiz, Porte, Pares, & Farres, 2012) . Interestingly, variants of other detoxifying enzymes, like glutathione transferases (GST) or glutathione reductases, are associated with allergic diseases Wu et al., 2007) . For instance, the I105V GSTP1-1 variant, resulting in defective conjugation of electrophilic drugs and GSH metabolites (Dragovic, Venkataraman, Begheijn, Vermeulen, & F I G U R E 5 Analysis of AKR1B1 mRNA levels by real-time RT-PCR. AKR1B1 expression levels were analyzed by real-time RT-PCR in MCF7 cells mock-transfected (−) or transfected with plasmids containing the ORF sequences for the wild-type (WT) or the c.398A>G (K90E) AKR1B1 mutant. The fold changes were evaluated using the HPRT1 (A), GAPDH (B), and 18S (C) genes as reference. The figure shows the mean ± SEM of three independent experiments. * P < 0.05 versus mocktransfected cells Commandeur, 2014) , has been associated with atopic (Hoskins, Wu, Reiss, & Dworski, 2013) , air pollution and acetaminophen-induced asthma (Kang et al., 2013; Su et al., 2013) .
According to the NCBI database (32) the rs2229542 variant presents an allele frequency of 4.7%. It produces the substitution of lysine 90 for glutamic acid (p.Lys90Glu), a drastic change affecting the charge and reactivity of the residue. Interestingly, the p.Lys90 residue is conserved in vertebrates from human to Xenopus laevis, whereas the zebrafish homolog displays a conservative change (arginine) ( Figure 7A ). In addition, p.Lys90 is conserved or substituted by arginine in several AKR family members, including AKR1B3, AKR1B7, AKR1B8, AKR1B10 (Petrash, 2004) , and AKR1B15 ( Figure 7B ), F I G U R E 6 Evaluation of AKR1B1 wild-type and p.Lys90Glu protein stability by Cellular Thermal Shift Assay. Lysates from MCF7 cells transfected with AKR1B1 wild-type (WT) or p.Lys90Glu (K90E) plasmids were subjected to different temperatures and centrifuged to obtain the supernatant and pellet fractions as described in Materials and Methods section. A: Supernatant (left) and pellet (right) fractions were analyzed by Western blot using antibodies against AKR1B1. * P < 0.05 versus WT samples. B: As a control, levels of AKR1A1 and HSP70 present in supernatant fractions from lysates of cells transfected with AKR1B1 WT or p.Lys90Glu, as indicated, were assessed by Western blot. Signals obtained upon densitometric scanning of the blots were represented as percentage of the total protein signal (supernatant + pellet = 100%) at each temperature. C: The melting temperature (T m ) is depicted for the three proteins studied. The graphs show the mean ± SEM of the T m values obtained in three independent experiments.
supporting the importance of a positively-charged residue at this position. However, the available information on the functional importance of this change is limited. In a previous study, no significant differences were found between the capacities of purified WT and p.Lys90Glu AKR1B1 to metabolize the antitumoral drug doxorubicin (Bains, Grigliatti, Reid, & Riggs, 2010) . Nevertheless, this type of assay cannot detect differences related to cellular expression levels or alterations in protein-protein interactions involving this enzyme.
According to the available crystal structure (1PWL), p.Lys90 is surface-exposed, and hence, putatively involved in interactions or subjected to posttranslational modifications. The organization of charged, polar, and polarizable residues in the tertiary structure of a protein creates large internal electrostatic fields, expected to affect many aspects of protein function, including molecular interactions and subcellular localization (Goryaynov & Yang, 2014; Reytor et al., 2009; Valero et al., 2010 ). The available AKR1B1 structure ( Figure 2E and F) shows the amino group at p.Lys90 lateral chain surrounded by negative charges. Therefore, the p.Lys90Glu mutation will drastically affect this area increasing the negative character, putatively eliciting repulsive effects between lateral chains of adjacent residues. Moreover, PredictProtein assigns a high score to the functional influence of the p.Lys90Glu mutation. Nevertheless, to the best of our knowledge, the rs2229542 variant has not been reported in association with other pathological situations.
Our initial experiments on the potential effect of AKR1B1 in the inflammatory response showed that the transfection of the WT enzyme attenuated cytokine-elicited ICAM-1 induction, whereas the p.Lys90Glu mutant did not. This lack of effect could be due, at least in part, to the lower protein levels consistently attained with the mutant construct. However, AKR1B1 transcript levels in cells transfected with WT or mutant constructs were indistinguishable, suggesting that the transcription efficiency of the two plasmids is similar. Our data suggest that, at least in cellular models, reduced levels of the p.Lys90Glu mutant protein could be related to translational or posttranslational mechanisms. Thus, the presence of the mutated codon could affect the folding or translation efficiency of the transcript. Additionally, the study of protein stability accomplished by CETSA showed that the presence of the p.Lys90Glu mutation moderately increased the susceptibility of the protein to thermal denaturation. This compromised stability could contribute to reduced protein levels and an alteration in the overall AKR1B1 function, including the detoxification of inflammatory mediators or, ultimately, the redox balance. Finally, it could be hypothesized that these alterations could influence the inflammatory processes underlying the development of the allergic responses.
Missense mutations resulting in decreased protein stability have been identified in several human diseases. Of note, a p.Cys164Tyr variant of the AKR family member AKR1C3, which has been detected in amyotrophic lateral sclerosis, shows decreased thermal stability, although it is not known whether this property leads to decreased protein levels in patients or contributes to disease mechanisms (Endo et al., 2017) .
Notably, in animal models the allergic response is ameliorated by strategies inhibiting AKR1B1, pointing to a deleterious role of AKR1B1 activity in this process, whereas our results could suggest a protective role. Nevertheless, it should be taken into account that, as other enzymes involved in the metabolism of electrophilic species and redox regulation, AKR1B1 could play a dual role in the modulation of inflammation. On one hand, this enzyme can detoxify reactive species, thus contributing to defense mechanisms (Kolb, Hunsaker, & Vander Jagt, 1994) . However, processing of high levels of reactive species could lead to generation of proinflammatory metabolites and/or depletion of antioxidant defenses, for which a positive inflammatory feedback may occur (Ramana et al., 2006) . Remarkably, AKR1B1 itself is a target for covalent modification by electrophilic species, which can stimulate or inhibit its activity depending on the modifying moiety Srivastava et al., 2003) . Therefore, understanding the involvement of AKR1B1 in a particular pathology requires detailed consideration of the multiple factors involved.
In summary, to the best of our knowledge, the present work is the first to report an association of the c.268A > G variant with allergic rhinitis in a patient cohort. These findings pave the way for new efforts to elucidate the potential association of this variant with other types of allergic reactions and to establish the role of AKR1B1 in the allergic response.
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